
š§¬Kate Neville - Part 3 | Fundamentals of IP Strategy for Biotechs | Safeguarding Discoveries & Technology | Aligning Science with Patents | Navigating Global Patent Considerations
Part 3 of 4: In this episode, Jon Chee hosts Kate Neville, PhD, Partner at Marshall Gersteināa law firm with over 60 years of expertise in delivering sophisticated intellectual property advice and legal services to leading businesses, research institutions, universities, and entrepreneurs worldwide. Kate is an accomplished attorney with a doctoral background in microbiology and immunology who specializes in global patent prosecution and strategic management. She has over a decade of experience, and works with a wide range of clients, from biotech startups to big pharma to non-profits. Kate has been recognized as a "World's Leading Patent Practitioner" by IAM magazine since 2013, an Illinois Super Lawyer since 2018, and is included in The Best Lawyers in AmericaĀ© for Patent Law.
The Biotech Startups Podcast Ā· Excedr
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
šGet your unique referral link here: refer.excedr.com/ZTHETY.
Part 3 of 4: In this episode, Jon Chee hosts Kate Neville, PhD, Partner at Marshall Gersteināa law firm with over 60 years of expertise in delivering sophisticated intellectual property advice and legal services to leading businesses, research institutions, universities, and entrepreneurs worldwide.
In this episode, youāll hear about:
- Building a strong foundation for your IP and the importance of well-crafted provisional applications.
- Aligning scientific advancements with proactive patent strategies to maximize long-term value.
- The critical timing for startups to address IP concerns, from tech transfer to scaling operations.
- The nuances of international patenting and strategic decisions on global protections.
- Practical tips for founders on prioritizing IP investments to strengthen their company and attract investors.
Enriched Notes:
Timestamps:
02:09 How to approach intellectual property (IP) as a biotech startup